Balancing the benefits and risks of inhaled long-acting beta-agonists--the influence of values

N Engl J Med. 2009 Apr 16;360(16):1592-5. doi: 10.1056/NEJMp0810561.

Author

Judith M Kramer¹

Affiliation

¹ Duke Translational Medicine Institute, Duke University Medical Center, Durham, NC, USA.

PMID: 19369665
DOI: 10.1056/NEJMp0810561

No abstract available

MeSH terms

Administration, Inhalation
Adrenergic beta-Agonists / adverse effects*
Adrenergic beta-Agonists / therapeutic use
Advisory Committees*
Asthma / drug therapy
Bronchodilator Agents / adverse effects
Bronchodilator Agents / therapeutic use
Delayed-Action Preparations
Drug Approval
Drug Labeling
Humans
Risk Assessment
United States
United States Food and Drug Administration*

Substances

Adrenergic beta-Agonists
Bronchodilator Agents
Delayed-Action Preparations